MNKD MarketBeat 5 days ago MannKind at Oppenheimer: 2025 Revenue Jumps 46%, Eyes $450M+ in 2026 on Afrezza and FUROSCIX
MNKD MT Newswires 6 days ago RBC Downgrades MannKind to Sector Perform From Outperform, Cuts Price Target to $3.50 From $7.50
